Tag
Sudhir Sethi
5 articles
Beryl Drugs EGM Passes Three Resolutions
Beryl Drugs Ltd held its Extra-Ordinary General Meeting on May 11, 2026, with 46 members present.
Shareholders passed three ordinary resolutions via e-voting and poll, including two director appointme
Beryl Drugs Promoter Acquires 7,500 Shares On-Market
Beryl Drugs Limited filed a SEBI Regulation 7(2) insider trading continual disclosure on 25 March 2026.
Promoter & Director Sudhir Sethi (DIN: 00090172) acquired 7,500 equity shares (0.14%) on-market
Beryl Drugs Promoter Acquires 7500 Shares Open Market
Beryl Drugs Ltd. files SEBI Regulation 29(2) disclosure for promoter Mr. Sudhir Sethi's open market share acquisition.
Sudhir Sethi acquired 7,500 equity shares (0.14%) on 24-March-2026, raising his h
Beryl Drugs Promoter Acquires 7500 Shares On-Market
Beryl Drugs Ltd discloses insider trading Form C under SEBI PIT Regulations 2015 for promoter share acquisition.
Promoter & Director Sudhir Sethi acquired 7,500 equity shares on BSE on 23 March 2026 f
Sudhir Sethi Acquires 7500 Beryl Drugs Shares
Beryl Drugs Limited discloses promoter Sudhir Sethi's acquisition of 7,500 equity shares (0.14%) via open market on 23 March 2026.
Post-acquisition, Sudhir Sethi's holding in Beryl Drugs rises from 9.